Population Health Investment, which is targeting therapeutics companies, plans to start trading today on the Nasdaq under PHICU. The offering covers 15 million shares priced at $10 per share. Read more.
Related Posts
Northern Star Investment III Prices Upsized $350M IPO
The SPAC plans to target businesses primarily in the direct-to-consumer and digitally-disruptive e-commerce spaces.
Cellebrite Registration Statement Now Effective on TWC Tech Holdings II Merger
The Israel-based tech firm plans to merge with the SPAC for $580 million in cash, including a $300 million PIPE.
Northern Star III and IV Add to Non-Redemption Agreements
In the latest agreements, identical to both SPACs, participating investors will hold onto 800,000 shares through the extension vote. In return, the parties would receive 200,000 sponsor shares if and when each SPAC completes a merger.
Genesis Growth Tech Secures 14 Extra Months to Close a Deal
The SPAC needs the extra time after mutually agreeing last month to terminate a deal with NextTrip.